1-Methylimidazole

1-Methylimidazole

SCHEMBL993256

CCOS(=O)(=O)O.Cn1ccnc1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NFKB1 P19838 1/20 0.52
QPCT Q16769 1/20 0.52
HSD17B10 Q99714 1/20 0.52
QPCTL Q9NXS2 1/20 0.52
TBXAS1 P24557 5/20 0.34
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 2/20 0.33
TP53 P04637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 1/20 0.33
EGLN3 Q9H6Z9 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid Diethyl Ester SCHEMBL17868367 0.86 NFKB1 (0.56) NFKB1QPCTHSD17B10QPCTLTBXAS1
1-Methylimidazole SCHEMBL27857093 0.83 QPCT (0.62) NFKB1QPCTHSD17B10QPCTLTBXAS1
Amylosulfuric Acid SCHEMBL5482271 0.83 NFKB1 (0.44) NFKB1QPCTHSD17B10QPCTLTBXAS1
SCHEMBL1582316 0.82 TBXAS1 (0.47) QPCTTBXAS1ALDH1A1KDM4EEGLN3
1-Methylimidazole SCHEMBL6672630 0.82 HSD17B10 (0.47) NFKB1QPCTHSD17B10QPCTLTBXAS1
1-Methylimidazole SCHEMBL993748 0.82 NFKB1 (0.60) NFKB1QPCTHSD17B10QPCTLALDH1A1
1-Methylimidazole SCHEMBL29110563 0.82 NFKB1 (0.60) NFKB1QPCTHSD17B10QPCTLTBXAS1
1-Methylimidazole SCHEMBL27681651 0.82 NFKB1 (0.60) NFKB1QPCTHSD17B10QPCTLALDH1A1
1-Methylimidazole SCHEMBL28257518 0.82 NFKB1 (0.60) NFKB1QPCTHSD17B10QPCTLALDH1A1
1-Methylimidazole SCHEMBL38665424 0.82 TBXAS1 (0.44) NFKB1QPCTHSD17B10QPCTLTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260088410-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS HENKEL AG & CO KGAA (DE) 2026-03-26 US claimed
US-12540262-B2 Two component (2K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2026-02-03 US claimed
US-12454635-B2 Two component (2K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2025-10-28 US claimed
US-12398302-B2 Two component (2K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2025-08-26 US claimed
WO-2025119658-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM HENKEL AG & CO. KGAA (DE) 2025-06-12 WO claimed
EP-4567085-A1 ELECTROCHEMICALLY DEBONDABLE ADHESIVE FILM Henkel AG & Co. KGaA (DE) 2025-06-11 EP claimed
US-12180398-B2 One component (1K) curable adhesive composition HENKEL AG & CO. KGAA (DE) 2024-12-31 US claimed
WO-2024260662-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS HENKEL AG & CO. KGAA (DE) 2024-12-26 WO claimed
EP-4481913-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS Henkel AG & Co. KGaA (DE) 2024-12-25 EP claimed
CN-114787314-B Two-component (2K) curable adhesive composition 汉高股份有限及两合公司 2024-11-29 CN claimed
WO-2021115772-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION HENKEL AG & CO. KGAA (DE) 2021-06-17 WO claimed
EP-3835381-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2021-06-16 EP claimed
EP-3835383-A1 ONE COMPONENT (1K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2021-06-16 EP claimed
EP-3835378-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2021-06-16 EP claimed
EP-3835386-A1 TWO COMPONENT (2K) CURABLE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2021-06-16 EP claimed
CN-111763968-A Plating solution for Co-Re-Cr nano-diamond wear-resistant ablation-resistant coating 济南东方结晶器有限公司 2020-10-13 CN claimed
EP-3328924-A1 METHODS AND SYSTEMS FOR PROCESSING MIXED TEXTILE FEEDSTOCK, ISOLATING CONSTITUENT MOLECULES, AND REGENERATING CELLULOSIC AND POLYESTER FIBERS Evrnu, SPC (US) 2018-06-06 EP claimed
WO-2017019802-A1 METHODS AND SYSTEMS FOR PROCESSING MIXED TEXTILE FEEDSTOCK, ISOLATING CONSTITUENT MOLECULES, AND REGENERATING CELLULOSIC AND POLYESTER FIBERS EVRNU, SPC (US) 2017-02-02 WO claimed
CN-105732507-A METHOD FOR PURIFYING A IONIC LIQUID AND METHOD FOR DEHUMIDIFYING AIR 赢创德固赛有限公司 2016-07-06 CN claimed
US-20110000823-A1 MEMBRANE DESULFURIZATION OF LIQUID HYDROCARBONS USING AN EXTRACTIVE LIQUID MEMBRANE CONTACTOR SYSTEM AND METHOD SAUDI ARABIAN OIL COMPANY (SA) 2011-01-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12540262-B2 Two component (2K) curable adhesive composition ILK, MAT2A, MMAB NFKB1 2294/4885QPCT 4017/4885HSD17B10 3465/4885
US-20260088410-A1 ELECTRONICS ASSEMBLY HAVING ELECTROCHEMICALLY DEBONDABLE COMPONENTS EPCAM, CDH1, ITGA4 NFKB1 3923/4885QPCT 2604/4885HSD17B10 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.